Minnesota investigates Sanofi for drug pricing
Credit: Wikipedia/Sanofi de
The state of Minnesota is investigating pharmaceutical company Sanofi for its pricing and trading practices for two diabetes treatment drugs, according to a securities filing last week.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10